MLKL and breast cancer: Therefore, all of the above-presented results indicate that the DS variant-mediated activation of NFκB affects the ability of these glycans to induce the MLKL phosphorylation in luminal breast cancer cells in a manner that is dependent on the structure of these molecules and the cancer cell type.